Stem Cell Therapy Market worth $330 Million in 2020 Stem Cell Therapy Market worth $330 Million in 202 | Page 19

Stem Cell Therapy Market PH 2438 – Regulatory Landscape, Pipeline Analysis, & Global Forecasts to 2020 LIST OF FIGURES CHAPTER 1: INTRODUCTION Stem Cell Therapy Market Segmentation, by Application Stem Cell Therapy Market Segmentation, by Mode of Therapy CHAPTER 4: PIPELINE ANALYSIS Pipeline Analysis: Based on Regulatory Authority, 2011–2013 Pipeline Analysis: Based on Country, 2011–2013 Pipeline Analysis: Based on Phase Under Clinical Trial, 2011–2013 Pipeline Analysis: Based on No. of Patients Enrolled, 2011–2013 Pipeline Analysis: Overall Therapy Based on Source of Cell Extraction, 2011–2013 Pipeline Analysis: Allogeneic Therapy Based on Clinical Trial Phases, 2011–2013 Pipeline Analysis: Autologous Therapy Based on Clinical Trial Phases, 2011–2013 Pipeline Analysis, by Application, 2011–2013 Pipeline Analysis: Allogeneic Therapy Based on Therapeutic Areas, 2011–2013 Pipeline Analysis: Autologous Therapy Based on Therapeutic Areas, 2011–2013 Overall Stem Cell Therapy Based on Cell Lines Used, 2011–2013 Allogeneic Stem Cell Therapy Based on Cell Lines Used, 2011–2013 Autologous Stem Cell Therapy Based on Cell Lines Used, 2011–2013 Pipeline Analysis of Stem Cell Therapy Market: Based on Major Companies, 2011–2013 CHAPTER 5: INVESTOR NETWORK Investor Network for Stem Cell Therapy Market: NIH (U.S.) Funding CHAPTER 6: GLOBAL STEM CELL THERAPY MARKET, BY MODE OF THERAPY 6.1: Introduction Stem Cell Therapy Market Segmentation, by Mode of Therapy Comparison Between Allogeneic & Autologous Stem Cell Therapy Estimated Cost Involved in the Manufacturing of Stem Cell Therapy Products [email protected] www.marketsandmarkets.com 19